ATE92077T1 - Enzymhemmer und methode zu dessen herstellung. - Google Patents
Enzymhemmer und methode zu dessen herstellung.Info
- Publication number
- ATE92077T1 ATE92077T1 AT88119126T AT88119126T ATE92077T1 AT E92077 T1 ATE92077 T1 AT E92077T1 AT 88119126 T AT88119126 T AT 88119126T AT 88119126 T AT88119126 T AT 88119126T AT E92077 T1 ATE92077 T1 AT E92077T1
- Authority
- AT
- Austria
- Prior art keywords
- analogues
- novel
- enzym
- inhibitor
- production
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 241000894007 species Species 0.000 abstract 2
- 102000004580 Aspartic Acid Proteases Human genes 0.000 abstract 1
- 108010017640 Aspartic Acid Proteases Proteins 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/826—Actinomyces
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62289995A JP2625129B2 (ja) | 1987-11-17 | 1987-11-17 | 酵素活性阻害剤及びその製造法 |
| EP88119126A EP0316907B1 (de) | 1987-11-17 | 1988-11-17 | Enzymhemmer und Methode zu dessen Herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE92077T1 true ATE92077T1 (de) | 1993-08-15 |
Family
ID=17750417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88119126T ATE92077T1 (de) | 1987-11-17 | 1988-11-17 | Enzymhemmer und methode zu dessen herstellung. |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US5087614A (de) |
| EP (1) | EP0316907B1 (de) |
| JP (1) | JP2625129B2 (de) |
| AT (1) | ATE92077T1 (de) |
| DE (1) | DE3882654T2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006050862A1 (en) | 2004-11-10 | 2006-05-18 | Boehringer Ingelheim International Gmbh | Statine derivatives for the treatment of alzheimer's disease |
| WO2006050861A2 (en) * | 2004-11-10 | 2006-05-18 | Boehringer Ingelheim International Gmbh | Statine derivatives for the treatment of alzheimer's disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0040435B1 (de) * | 1980-05-20 | 1983-07-20 | Eisai Co., Ltd. | Peptidderivate und Verfahren zu ihrer Herstellung |
| US4479941A (en) * | 1981-12-10 | 1984-10-30 | Merck & Co., Inc. | Renin inhibitory peptides having PHE13 delection |
| EP0184855A3 (de) * | 1984-12-14 | 1989-05-03 | Abbott Laboratories | Reninhemmende Verbindungen |
| US4735933A (en) * | 1986-12-15 | 1988-04-05 | Warner-Lambert Company | Renin inhibitors III |
| US4874745A (en) * | 1987-10-01 | 1989-10-17 | Merck & Co., Inc. | Renin-inhibitory pepstatin phenyl derivatives |
-
1987
- 1987-11-17 JP JP62289995A patent/JP2625129B2/ja not_active Expired - Lifetime
-
1988
- 1988-11-16 US US07/271,965 patent/US5087614A/en not_active Expired - Fee Related
- 1988-11-17 DE DE88119126T patent/DE3882654T2/de not_active Expired - Fee Related
- 1988-11-17 AT AT88119126T patent/ATE92077T1/de active
- 1988-11-17 EP EP88119126A patent/EP0316907B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0316907A2 (de) | 1989-05-24 |
| EP0316907B1 (de) | 1993-07-28 |
| DE3882654T2 (de) | 1993-12-16 |
| DE3882654D1 (de) | 1993-09-02 |
| EP0316907A3 (en) | 1990-09-12 |
| US5087614A (en) | 1992-02-11 |
| JP2625129B2 (ja) | 1997-07-02 |
| JPH01132599A (ja) | 1989-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE131161T1 (de) | Substanz pf 1022, verfahren zu ihrer herstellung und diese substanz enthaltende anthelmintische zusammensetzung. | |
| HUP0100723A2 (hu) | Indolszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
| AU8581991A (en) | Mercaptoacetylamide derivatives as inhibitors of enkephalinase and ACE, and processes for their production | |
| IL109780A0 (en) | Saccharin derivative proteolytic enzyme inhibitors, their preparation and pharmaceutical compositions containing them | |
| HUT43582A (en) | Process for production of derivatives of 4,5,6-substituated-n-/substituated phenil/-piramidin-amin and medical compounds containing thereof | |
| FI925787A0 (fi) | Proteolytiska enzymers sackarinderivatinhibitorer | |
| CS38989A2 (en) | Method of phenoxyacetamidoderivative production | |
| ATE56211T1 (de) | 2-phenylbenzoxepin-derivat. | |
| AT379800B (de) | Verfahren zur herstellung von neuen 2-oxazetidin-derivaten | |
| NO894349L (no) | Tienopyridin-type mevalonolaktoner. | |
| ATE82326T1 (de) | Verfahren zur herstellung von organischen chemischen verbindungen. | |
| BR0001342A (pt) | Processo para a produção de l-aminoácidos por meio de fermentação usando bactérias corineformes | |
| DE68903907D1 (de) | Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen. | |
| DK347788D0 (da) | Teicoplaninlignende forbindelser, fremgangsmaade og mikroorganisme til fremstilling deraf og farmaceutisk praeparat indeholdende saadanne forbindelser | |
| ES2023560A6 (es) | Procedimiento para la produccion de hidrato de cefradina y solvato de cefradina y dimetilformamida. | |
| ATE92077T1 (de) | Enzymhemmer und methode zu dessen herstellung. | |
| DE69133494D1 (de) | Microbiologische Herstellung von L-Ascorbinsäure | |
| ES2085403T3 (es) | Gen de origen microbiano para peroxidasa. | |
| PL338348A1 (en) | Thiazolobenzenoheterocyclic compounds, their production and drugs containing them | |
| ATE70262T1 (de) | Azoxyverbindungen und verfahren zu ihrer herstellung. | |
| NZ332245A (en) | Substituted benzo-oxazolol carboxylic acid derivatives, process for their production and medicaments containing them | |
| ATE123028T1 (de) | Phospholipase-a2-inhibitor, verfahren zu seiner herstellung und diesen enthaltende pharmazeutische oder veterinäre zusammensetzungen. | |
| BG108151A (en) | Caloporoside derivatives, methods for the production thereof and their use | |
| ATE191508T1 (de) | Mikrobiologisches verfahren zur herstellung von 1-ungesättigten, 17-beta-carboxysubstituierten 3- oxo-4-azaandrostan-3-onen | |
| NO881812D0 (no) | Fremgangsmaate for fremstilling av krystallinsk n-(s-3-metylheptanoyl)-d-gamma-glutamyl-glycyl-d-alanin og mellomprodukter for fremstillingen. |